It has previously been reported in patients with RC who underwent preoperative chemoradiotherapy that the CD133, OCT4, and SOX2 markers could be useful for predicting distant recurrence and poor prognosis, in addition to their possible association with tumor regrowth and metastases after chemoradiotherapy. This evidence concerns the gene SOX2 and neoplasm.